# Bio-Inno

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bio-inno

- Industry: Biotechnology
- Headquarters: Wuhan, China
- Latest round: Series A (Jun 10, 2026)
- Investors on record: 6

## About

Based in Wuhan, China and founded in 2021, Wuhan Bio-Inno Biotechnology Co., Ltd., dba Bio-Inno, operates as an immunotherapy developer that provides mid- to late-stage immunotherapy for oncology, cancer diagnostics, and peptide drug development. In January 2022, the company signed a research cooperation agreement with Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology. In June 2026, Bio-Inno closed Series A funding led by Yangtze River Industry Fund, with participation from Wuchuang Capital, Herbal Gold Formula Health Technology (Guangdong) Co., Ltd., Perfect Medical, Yuanmiao (Zhuhai Hengqin).

The company's business integrates basic research, product development, production and sales. The main products are antibody reagents for auxiliary diagnosis, diagnostic reagents for immunohistochemistry, and peptide anti-thoracic fluid drugs. The company also provides clinical testing services. The company's two core products, PD-L1 concomitant diagnostic kit "Inocon", can improve the specificity of the test, and the new anti-tumor cell metastasis peptide "Inotec", which controls the problem of chest and abdominal fluid by inhibiting the activity and metastasis of cancer cells.

The company generate revenue from providing diagnostic services for mid- to late-stage cancer immunotherapy.

## Funding rounds

- Series A, Jun 10, 2026 — Yangtze River Industry Fund, Wuchuang Capital, Herbal Gold Formula Health Technology (Guangdong) Co., Ltd., Perfect Medical
- Seed, Aug 11, 2022 — Dongke Chuangxing Venture Capital, Baiying Bio-industry Investment

## Investors

- Dongke Chuangxing Venture Capital — Seed
- Baiying Bio-industry Investment (https://capitalatlas.ai/funds/baiying-bio-industry-investment) — Seed
- Yangtze River Industry Fund (https://capitalatlas.ai/funds/yangtze-river-industry-fund) — Series A
- Wuchuang Capital (https://capitalatlas.ai/funds/wuchuang-capital) — Series A
- Herbal Gold Formula Health Technology (Guangdong) Co., Ltd. — Series A
- Perfect Medical — Series A